Archive - March 2019
NCI head Sharpless named as interim FDA chief
Medicine as a service should be the ‘new norm’
NICE partially clears Darzalex combo in blood cancer
Finalists announced for the 2019 PharmaTimes International Clinical Researcher of the Year!
Brexit deal defeated again, crucial no-deal vote awaits
Lilly’s Cyramza hits first-line NSCLC trial targets
AZ links with Seres in microbiome cancer immunotherapy pact
Chemistry professionals say no-deal Brexit negative for UK science